why choose us

First received: November 30, 2022

Clinical Trial: Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients

Study Status: Completed

Recruit Status: Completed

Condition: Small Cell Lung Cancer

Study Type: Observational


Official Title: Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients

Brief Summary: In this retrospective study, patients diagnosed with SCLC between January 2011 to September 2022 were identified from database of the Second Hospital of Shandong University. Following inclusion criteria should be met: (1) Had histologically or cytologically confirmed newly diagnosed SCLC; (2) No cancer treatment has been done before; (3) Complete clinical, laboratory, imaging, treatment data and follow-up information. The exclusion criteria included: Patients without complete records for pathological information,…

Read more